pirlimycin has been researched along with novobiocin in 4 studies
| Studies (pirlimycin) | Trials (pirlimycin) | Recent Studies (post-2010) (pirlimycin) | Studies (novobiocin) | Trials (novobiocin) | Recent Studies (post-2010) (novobiocin) |
|---|---|---|---|---|---|
| 55 | 8 | 16 | 2,271 | 15 | 290 |
| Protein | Taxonomy | pirlimycin (IC50) | novobiocin (IC50) |
|---|---|---|---|
| DNA gyrase subunit B | Mycolicibacterium smegmatis MC2 155 | 0.046 | |
| DNA gyrase subunit B | Staphylococcus aureus | 0.0474 | |
| DNA gyrase subunit B | Streptococcus pneumoniae TIGR4 | 0.037 | |
| DNA gyrase subunit A | Escherichia coli K-12 | 0.1441 | |
| DNA gyrase subunit B | Escherichia coli K-12 | 0.1537 | |
| DNA topoisomerase 4 subunit B | Staphylococcus aureus | 7.9 | |
| DNA gyrase subunit B | Mycolicibacterium smegmatis | 0.161 | |
| DNA gyrase subunit A | Staphylococcus aureus | 0.0383 | |
| DNA gyrase subunit B | Mycobacterium tuberculosis H37Rv | 0.0446 | |
| DNA gyrase subunit A | Mycobacterium tuberculosis H37Rv | 0.1315 | |
| DNA topoisomerase | Streptococcus pneumoniae | 2.03 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ford, CW; Kinney, ML; Yancey, RJ | 1 |
| Aarestrup, FM; Pankey, JW; Salmon, SA; Watts, JL; Yancey, RJ | 1 |
| Chester, ST; Dowlen, HH; Gillespie, BE; Hallberg, JW; Ivey, SJ; Johnson, DL; Lamar, KC; Lewis, MJ; Moorehead, H; Oliver, SP | 1 |
| Dowlen, HH; Gillespie, BE; Hallberg, JW; Headrick, SI; Johnson, DL; Lamar, KC; Lewis, MJ; Moorehead, H; Oliver, SP | 1 |
4 other study(ies) available for pirlimycin and novobiocin
| Article | Year |
|---|---|
Efficacy of lincosaminide antibiotics in the treatment of experimental staphylococcal mastitis in lactating mice.
Topics: Animals; Anti-Bacterial Agents; Cattle; Clindamycin; Cloxacillin; Disease Models, Animal; Female; Injections; Injections, Subcutaneous; Kinetics; Lactation; Lincomycin; Lincosamides; Macrolides; Mammary Glands, Animal; Mastitis; Mastitis, Bovine; Mice; Microbial Sensitivity Tests; Novobiocin; Pregnancy; Rifamycins; Staphylococcal Infections | 1985 |
Minimum inhibitory concentrations for selected antimicrobial agents against organisms isolated from the mammary glands of dairy heifers in New Zealand and Denmark.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Cattle; Cephalosporins; Clindamycin; Denmark; Enrofloxacin; Erythromycin; Female; Fluoroquinolones; Mammary Glands, Animal; Mastitis, Bovine; Microbial Sensitivity Tests; New Zealand; Novobiocin; Penicillins; Quinolones; Staphylococcus; Staphylococcus aureus | 1998 |
Influence of prepartum pirlimycin hydrochloride or penicillin-novobiocin therapy on mastitis in heifers during early lactation.
Topics: Animals; Anti-Bacterial Agents; Cattle; Clindamycin; Drug Therapy, Combination; Female; Lactation; Mammary Glands, Animal; Mastitis, Bovine; Novobiocin; Penicillins; Pregnancy; Random Allocation; Staphylococcus; Streptococcus; Treatment Outcome | 2004 |
Intramammary infections in heifers during early lactation following intramammary infusion of pirlimycin hydrochloride or penicillin-novobiocin at the first milking after parturition.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Cattle; Cattle Diseases; Clindamycin; Female; Infusions, Parenteral; Mammary Glands, Animal; Milk; Novobiocin; Parturition; Penicillins; Pregnancy | 2007 |